Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Sunshine Biopharma Inc. - Common stock
(NQ:
SBFM
)
1.390
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 25, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
70,051
Open
1.370
Bid (Size)
1.300 (100)
Ask (Size)
1.530 (100)
Prev. Close
1.390
Today's Range
1.340 - 1.390
52wk Range
1.169 - 3.900
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)
October 28, 2025
Via
ACCESS Newswire
Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea
October 28, 2025
Via
ACCESS Newswire
Performance
YTD
-55.6%
-55.6%
1 Month
-29.1%
-29.1%
3 Month
-4.1%
-4.1%
6 Month
-2.8%
-2.8%
1 Year
-43.0%
-43.0%
More News
Read More
Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline
October 20, 2025
Via
ACCESS Newswire
Sunshine Biopharma Stock Powers Ahead Following Launch Of Generic Cholesterol-Lowering Drug By Canadian Unit
↗
October 16, 2025
Via
Stocktwits
Sunshine Biopharma Stock Is Surging Thursday: Here's What's Happening
↗
October 16, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
October 16, 2025
Via
Benzinga
Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin
October 16, 2025
Via
ACCESS Newswire
Sunshine Biopharma Stock is 34% Higher Since September as Investors Reward Performance Combined with Innovation (NASDAQ: SBFM)
October 16, 2025
Via
AB Newswire
Sunshine Biopharma is Proving That Riding Momentum is an Effective Strategy (NASDAQ:SBFM)
October 14, 2025
Via
ACCESS Newswire
Sunshine Biopharma Proves Microcap Ambition Can Deliver Large-Cap Level Execution (NASDAQ: SBFM)
October 14, 2025
Via
ACCESS Newswire
Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience
October 14, 2025
Via
ACCESS Newswire
Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections
October 09, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
August 12, 2025
Via
Benzinga
Sunshine Biopharma Stock Soars After Launch Of First Biosimilar In $10B Canadian Market: Retail Bulls Charge In
↗
July 02, 2025
Via
Stocktwits
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
July 02, 2025
Via
Benzinga
Sunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics Market
July 02, 2025
Via
ACCESS Newswire
Sunshine Biopharma Unit Launches Generic Anticonvulsant In Canada: Retail Sees ‘Huge Potential’
↗
June 11, 2025
Via
Stocktwits
Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion Market
June 11, 2025
Via
ACCESS Newswire
Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year
May 15, 2025
Via
ACCESS Newswire
Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market
May 06, 2025
Via
ACCESS Newswire
Sunshine Biopharma Boosts Retail Trader Appeal After Canadian Launch Of Generic Cancer Drug
↗
April 21, 2025
Via
Stocktwits
The market is filled with gapping stocks in Monday's session.
↗
April 21, 2025
Via
Chartmill
What's going on in today's pre-market session
↗
April 21, 2025
Via
Chartmill
Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion
April 21, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
April 21, 2025
Via
Benzinga
Frequently Asked Questions
Is Sunshine Biopharma Inc. - Common stock publicly traded?
Yes, Sunshine Biopharma Inc. - Common stock is publicly traded.
What exchange does Sunshine Biopharma Inc. - Common stock trade on?
Sunshine Biopharma Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Sunshine Biopharma Inc. - Common stock?
The ticker symbol for Sunshine Biopharma Inc. - Common stock is SBFM on the Nasdaq Stock Market
What is the current price of Sunshine Biopharma Inc. - Common stock?
The current price of Sunshine Biopharma Inc. - Common stock is 1.390
When was Sunshine Biopharma Inc. - Common stock last traded?
The last trade of Sunshine Biopharma Inc. - Common stock was at 11/25/25 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today